Clinical outcomes, medical costs, and medication usage patterns of different somatic symptom disorders and functional somatic syndromes: 2023 Wu et al

Discussion in 'Psychosomatic research - ME/CFS and Long Covid' started by Andy, Nov 21, 2023.

  1. Andy

    Andy Committee Member

    Messages:
    22,312
    Location:
    Hampshire, UK
    Full title: Clinical outcomes, medical costs, and medication usage patterns of different somatic symptom disorders and functional somatic syndromes: a population-based study in Taiwan

    Background
    Somatic symptom disorders (SSD) and functional somatic syndromes (FSS) are often regarded as similar diagnostic constructs; however, whether they exhibit similar clinical outcomes, medical costs, and medication usage patterns has not been examined in nationwide data. Therefore, this study focused on analyzing SSD and four types of FSS (fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, functional dyspepsia).

    Methods
    This population-based matched cohort study utilized Taiwan's National Health Insurance (NHI) claims database to investigate the impact of SSD/FSS. The study included 2 615 477 newly diagnosed patients with SSD/FSS and matched comparisons from the NHI beneficiary registry. Healthcare utilization, mortality, medical expenditure, and medication usage were assessed as outcome measures. Statistical analysis involved Cox regression models for hazard ratios, generalized linear models for comparing differences, and adjustment for covariates.

    Results
    All SSD/FSS showed significantly higher adjusted hazard ratios for psychiatric hospitalization and all-cause hospitalization compared to the control group. All SSD/FSS exhibited significantly higher adjusted hazard ratios for suicide, and SSD was particularly high. All-cause mortality was significantly higher in all SSD/FSS. Medical costs were significantly higher for all SSD/FSS compared to controls. The usage duration of all psychiatric medications and analgesics was significantly higher in SSD/FSS compared to the control group.

    Conclusion
    All SSD/FSS shared similar clinical outcomes and medical costs. The high hazard ratio for suicide in SSD deserves clinical attention.

    Paywall, https://www.cambridge.org/core/jour...dy-in-taiwan/2A833C3B54DB2226E931ABA867DA3FA5
     
  2. rvallee

    rvallee Senior Member (Voting Rights)

    Messages:
    12,924
    Location:
    Canada
    Twiddle Dee and Twiddle Dum look alike? Uh, who would have thought?

    Also, it's kind of expensive to be this bad at your job. For everyone. But they can't imagine being wrong so this nonsense never stops. Evidence-based medicine cannot die soon enough. It is an abysmal failure.
     
  3. Sean

    Sean Moderator Staff Member

    Messages:
    7,495
    Location:
    Australia
    Which is what you would expect to see in patients who are persistently misdiagnosed and mistreated for decades.

    It tells us absolutely nothing about the validity of the SSD/FSS constructs.
     
    RedFox, Trish and shak8 like this.

Share This Page